Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
HIV Eradication: One Step Closer
Scientists Crack Integrase Inhibitor Mystery
Gilead Reports Success With Quad Pill and Boosting Drug
New Hope for HIV Eradication
Study: Demand for HIV Vaccine Will Depend on How Good It Is
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

April 28, 2008

Better Antibiotics for Second-Line PCP Treatment

A combination of two oral antibiotics is more effective than the commonly used, yet side effect-prone, intravenous pentamidine for people who’ve failed their first AIDS-related pneumonia regimen, according to the authors of a new study published in the May 1 issue of the Journal of Acquired Immune Deficiency Syndromes (JAIDS). Data supporting the use of clindamycin and primaquine is promising news for the roughly 10 percent of patients whose first course of treatment for Pneumcystis jirovecii pneumonia (PCP) doesn’t work.

Intravenous pentamidine is known for a range of serious side effects, including kidney toxicity, low blood pressure and low white blood cell count, and has been shown less effective as treatment for PCP than the antibiotic trimethoprim-sulfamethoxazole (TMP-SMX), commonly known as Bactrim or Septra. For this reason, pentamidine is typically recommended only as second-line therapy for those who don’t respond effectively to their initial treatment choice, or as first-line treatment for people who cannot tolerate TMP-SMX. There are alternatives to pentamidine, but there has been little research to show how effective they may be in treating people who fail their first PCP regimen.

Thomas Benfield, MD, DMSci, from the Department of Infectious Diseases at Hvidovre University Hospital in Copenhagen, Denmark, and his colleagues conducted an analysis of 29 published studies, plus an additional 82 case reports from three European cities. In all, they were able to study the outcomes of 468 second-line PCP treatment episodes.

Benfield’s team found intravenous pentamidine was effective 44 percent of the time in curing cases of PCP in people who’d failed their first treatment. However, the cure rate was far higher (73 percent) in people who took clindamycin and primaquine, which are also less likely to cause serious side effects than pentamidine.

Benfield’s group recommends that clindamycin-primaquine now be used as second-line treatment in people with PCP who fail on TMP-SMX, or who cannot tolerate TMP-SMX.

Search: pentamidine, trimethoprim, sulfamethoxazole, TMP-SMX, Bactrim, Septra, clindamycin, primaquine, Thomas, Benfield, Hvidovre, University, pnumocystis, jerovecii, pneumonia, PCP


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)
San Francisco, CA
February 16-19, 2010


5th IAS Conference on HIV Pathogenesis Treatment and Prevention (IAS 2009)
Cape Town, South Africa
July 19-22, 2009


16th Conference on Retroviruses and Opportunistic Infections (CROI 2009)
Montréal, Canada
February 8-11, 2009

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy